Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 110,897,279
Number of holders: 24
Total 13F shares, excl. options: 2,013,500
Shares change: +2,013,500
Total reported value, excl. options: $19,489,000
Value change: +$19,489,000
Number of buys: 24
Price: $9.68

Significant Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q4 2020

24 filings reported holding IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,013,500 shares of 110,897,279 outstanding shares and own 1.8% of the company stock.
Largest 10 shareholders include Alpine Global Management, LLC (790,208 shares), Prentice Capital Management, LP (416,667 shares), FMR LLC (340,356 shares), Cerity Partners LLC (122,546 shares), BlackRock Inc. (71,752 shares), MILLENNIUM MANAGEMENT LLC (67,863 shares), Granite Point Capital Management, L.P. (66,666 shares), Kepos Capital LP (66,666 shares), NORTHERN TRUST CORP (25,287 shares), and GEODE CAPITAL MANAGEMENT, LLC (15,180 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.